Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Not yet recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 7INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2

Interventions

Injections 37Carboplatin 32Paclitaxel 24Docetaxel 24Capecitabine 24Gemcitabine 22Oxaliplatin 21Cisplatin 21pembrolizumab 20Bevacizumab 19Pemetrexed 18Irinotecan 13Fluorouracil 13Cyclophosphamide 11Nivolumab 9osimertinib 8Dexamethasone 8Topotecan 7Leucovorin 7toripalimab 6tislelizumab 6regorafenib 6lenvatinib 6fludarabine 6Trastuzumab 6Doxorubicin 6Cetuximab 6130-nm albumin-bound paclitaxel 6venetoclax 5Temozolomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Indocyanine Green × Clear all
NCT07254845 2025-11-28

A PROSPECTIVE, SINGLE-CENTERED, ASSESSOR-BLINDED STUDY TO EVALUATE THE CLINICAL EFFICACY OF THE PROPOSED CELL/TISSUE HISTOPATHOLOGY PROCESSOR CCELL (CONFOCAL FLUORESCENCE ENDOMICROSCOPY) FOR INTRAOPERATIVE DIAGNOSIS IN BRAIN TUMORS

VPIX Medical

Phase 1 Not yet recruiting
30 enrolled
CNS

Brain Neoplasms

NCT06867978 2025-03-10

PRECISION

VPIX Medical

Phase 1 Not yet recruiting
100 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡